Clinical Trial Update: Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 trial exploring intranasal dexmedetomidine combined with oral midazolam for premedication in anxious pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)
• Midazolam (oral) (Midazolam)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Anxiety | Phase 4 | Status: UNKNOWN